Technology area: Biotechnology & Pharmaceuticals
67 pending office actions • 44 art units • 64 examiners • 0 of 67 (0%) have an AI response strategy ready • 49 patents granted in the last 365 days
Yale University has 67 pending office actions in Biotechnology & Pharmaceuticals. The docket spans 64 distinct examiners and 44 art units, reflecting broad technical and examiner distribution. The examiner count is close to the pending-action count, while the lower art-unit count indicates that multiple matters are handled within some art units.
GONZALEZ, LUISALBERTO is the busiest examiner, with 2 pending matters. That is the only stated examiner concentration in the profile, so the docket is not organized around a single recurring examiner. Portfolio management should combine centralized tracking of biotechnology and pharmaceutical claim themes with art-unit-specific review of examination practice.
Based on the USPTO statutory response window for each pending office action. 17 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 17 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 5 (7%) |
| §103 only | 17 (25%) |
| §102 only | 5 (7%) |
| §112 only | 4 (6%) |
| Double-patenting only | 2 (3%) |
| Double-patenting + other | 10 (15%) |
| Multi-statute (no §101) | 23 (34%) |
| No statute on record | 1 (1%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GONZALEZ, LUISALBERTO | 2 | 59.7% | +46.3% |
| MONTANARI, DAVID A | 2 | 64.8% | +49.0% |
| FLINDERS, JEREMY C | 2 | 63.5% | +17.0% |
| SAHAND, SANA | 1 | 63.5% | +24.0% |
| MOSS, JAMES R | 1 | 51.1% | +41.6% |
| PACKARD, BENJAMIN J | 1 | 66.9% | +15.3% |
| MAEWALL, SNIGDHA | 1 | 58.8% | +10.5% |
| SUO, JOSHUA JUNGWOOK | 1 | 72.7% | +30.0% |
| TRAN, VIVIAN AILINH | 1 | 55.7% | +43.5% |
| GEBRESLASSIE, WINTA | 1 | 77.6% | +20.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18266917 | USE OF MGLUR5 ANTAGONISTS FOR TREATING GAMBLING DISORDER | ROZOF, TIMOTHY R | 49d overdue |
| 17768166 | TARGETED BIFUNCTIONAL DEGRADERS | GOTFREDSON, GAREN | 30d overdue |
| 17641516 | NANOPARTICLES FOR SELECTIVE TISSUE OR CELLULAR UPTAKE | LAZARO, DOMINIC | 30d overdue |
| 18557008 | ON-CHIP SPECTROMETER WITH TUNABLE PHOTODETECTION LAYER | LIU, BENJAMIN T | 26d overdue |
| 18555112 | COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF CANCER | COUGHLIN, MATTHEW P | 13d |
| 17289882 | Quantitative Algorithm for Endometriosis | LIU, GUOZHEN | 13d |
| 18623722 | EGFR PROTEOLYSIS TARGETING CHIMERIC MOLECULES AND ASSOCIATED METHODS OF USE | DAHLIN, HEATHER RAQUEL | 53d |
| 19175271 | INTRACAVITARY, PHYSIOLOGICAL AUGMENTATION DEVICE AND METHOD | SAHAND, SANA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17764804 | DETERMINISTIC BARCODING FOR SPATIAL OMICS SEQUENCING | FLINDERS, JEREMY C | 28d overdue |
| 19175271 | INTRACAVITARY, PHYSIOLOGICAL AUGMENTATION DEVICE AND METHOD | SAHAND, SANA | — |
| 19077565 | INTRACARDIAC DEVICE | MOSS, JAMES R | — |
| 19111224 | Methods of Managing Traumatic Brain Injury | PACKARD, BENJAMIN J | — |
| 19023761 | HYPERBRANCHED POLYGLYCEROL-COATED PARTICLES AND METHODS OF MAKING AND USING THEREOF | MAEWALL, SNIGDHA | — |
| 18987814 | METHODS OF INCORPORATING SPORADIC OBJECTS ONTO AN EXISTING MESH | SUO, JOSHUA JUNGWOOK | — |
| 18852059 | COMPACT SCALABLE DISSOLVED OXYGEN SENSOR | TRAN, VIVIAN AILINH | — |
| 18900131 | METHODS FOR GENERATION OF SYNTHETIC SV2A PET FROM MRI IMAGES | GEBRESLASSIE, WINTA | — |
| Art Unit | Apps |
|---|---|
| 1632 | 4 |
| 1612 | 3 |
| 1619 | 3 |
| 1638 | 3 |
| 1629 | 3 |
| 1645 | 3 |
| 1684 | 3 |
| 1622 | 2 |
| 3791 | 2 |
| 1626 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19175271 | INTRACAVITARY, PHYSIOLOGICAL AUGMENTATION DEVICE AND METHOD | SAHAND, SANA | 3796 | §102§103§112 | Non-Final OA | — | Pending | Apr 10, 2025 |
| 19077565 | INTRACARDIAC DEVICE | MOSS, JAMES R | 3792 | §103§112DP | Non-Final OA | — | Pending | Mar 12, 2025 |
| 19111224 | Methods of Managing Traumatic Brain Injury | PACKARD, BENJAMIN J | 1612 | §103 | Non-Final OA | — | Pending | Mar 12, 2025 |
| 19023761 | HYPERBRANCHED POLYGLYCEROL-COATED PARTICLES AND METHODS OF MAKING AND USING THEREOF | MAEWALL, SNIGDHA | 1612 | DP | Non-Final OA | — | Pending | Jan 16, 2025 |
| 18987814 | METHODS OF INCORPORATING SPORADIC OBJECTS ONTO AN EXISTING MESH | SUO, JOSHUA JUNGWOOK | 2616 | §103 | Non-Final OA | — | Pending | Dec 19, 2024 |
| 18852059 | COMPACT SCALABLE DISSOLVED OXYGEN SENSOR | TRAN, VIVIAN AILINH | 1794 | §103§112 | Non-Final OA | — | Pending | Sep 27, 2024 |
| 18900131 | METHODS FOR GENERATION OF SYNTHETIC SV2A PET FROM MRI IMAGES | GEBRESLASSIE, WINTA | 2677 | §103 | Non-Final OA | — | Pending | Sep 27, 2024 |
| 18849428 | BIODEGRADABLE CONTROLLED RELEASE ANTIVIRAL AGENT IMPLANTS | BURKE, MATTHEW RYAN | 1619 | §103 | Non-Final OA | — | Pending | Sep 20, 2024 |
| 18840303 | MULTIPLEXED REPRESSION OF IMMUNOSUPPRESSIVE GENES | GRABER, JAMES J | 1631 | §102 | Non-Final OA | — | Pending | Aug 21, 2024 |
| 18840040 | METHODS OF TREATING, AMELIORATING, OR PREVENTING HEART FAILURE, AND METHODS OF PROMOTING HEART MUSCLE GROWTH | WHITE, DAWANNA SHAR-DAY | 1627 | §102§103§112 | Non-Final OA | — | Pending | Aug 20, 2024 |
| 18806178 | BI-FUNCTIONAL MOLECULES TO DEGRADE CIRCULATING PROTEINS | SCHMITT, MICHAEL J | — | Other | Non-Final OA | — | Pending | Aug 15, 2024 |
| 18794166 | DERMATOLOGIC TOPICAL APPLICATIONS OF ROR GAMMA AND ROR GAMMA-T INHIBITORS FOR THE PREVENTION OF SKIN CANCER DEVELOPMENT | CARR, DEBORAH D | 1691 | §102§103§112 | Non-Final OA | — | Pending | Aug 05, 2024 |
| 18835094 | PROBE FOR MONITORING RNA SPLICING AND METHODS THEREOF | KOVACH, KARA NICOLE | 1681 | §102§103§112 | Non-Final OA | — | Pending | Aug 01, 2024 |
| 18744344 | MULTIBLOCK COPOLYMER FILMS, METHODS OF MAKING SAME, AND USES THEREOF | MENON, KRISHNAN S | 1771 | DP | Non-Final OA | — | Pending | Jun 14, 2024 |
| 18718839 | STRETCHABLE, FABRIC SENSOR, WEARABLE ELECTRONIC DEVICE INCLUDING THE SAME, AND METHOD OF MAKING THE SAME | FREAL, JOHN BRENDAN | 2847 | §102§103 | Non-Final OA | — | Pending | Jun 12, 2024 |
| 18715012 | HUMAN CORTICAL ORGANOIDS WITH ENGINEERED MICROGLIA-LIKE CELLS | ROGERS, ERIC JASON | 1638 | §103§112 | Non-Final OA | — | Pending | May 30, 2024 |
| 18653162 | Bioprinting of Collagenous Bioinks | SWANSON, ANDREW L | 1745 | §103 | Final Rejection | — | Pending | May 02, 2024 |
| 18701027 | IMPROVED SELECTIVE JAK2 INHIBITORS AND METHODS OF USE | VAJDA, KRISTIN ANN | 1622 | §102§103§112DP | Non-Final OA | — | Pending | Apr 12, 2024 |
| 18623722 | EGFR PROTEOLYSIS TARGETING CHIMERIC MOLECULES AND ASSOCIATED METHODS OF USE | DAHLIN, HEATHER RAQUEL | 1629 | §103§112Other | Non-Final OA | 53d | Pending | Apr 01, 2024 |
| 18694284 | COMPOUNDS AND METHODS FOR TREATING CANCERS THAT ARE MGMT DEFICIENT REGARDLESS OF MMR STATUS | NEAGU, IRINA | 1629 | §103§112 | Non-Final OA | — | Pending | Mar 21, 2024 |
| 18692729 | NANOPARTICLE SURFACE TOPOGRAPHY MODIFIED WITH BOTTLEBRUSH BLOCK COPOLYMERS | ABBAS, ABDULRAHMAN MUSTAFA | 1612 | §103 | Non-Final OA | — | Pending | Mar 15, 2024 |
| 18690785 | METHODS, SYSTEMS AND COMPOSITIONS FOR RESTORATION AND PRESERVATION OF INTACT ORGANS IN A MAMMAL | YOH, JULIUS FRANCIS | 1799 | §102§112DP | Non-Final OA | — | Pending | Mar 11, 2024 |
| 18684124 | COMPOSITIONS AND METHODS FOR GENERATING TICK IMMUNITY | GRASER, JENNIFER E | 1645 | §101§102§103§112DP | Non-Final OA | — | Pending | Feb 15, 2024 |
| 18683106 | COMPOSITIONS FOR ORGAN AND TISSUE PRESERVATION | GONZALEZ, LUISALBERTO | 1632 | §102§103DP | Non-Final OA | — | Pending | Feb 12, 2024 |
| 18681192 | LEPTOSPIRAL VIRULENCE MODULATING PROTEINS AND USES THEREOF | DUFFY, PATRICIA ANN | 1645 | §101§102§112 | Non-Final OA | — | Pending | Feb 05, 2024 |
| 18571471 | ANTI-CANCER COMPOUNDS AND METHODS OF USE | GONZALEZ, LUISALBERTO | 1624 | §102 | Final Rejection | — | Pending | Dec 18, 2023 |
| 18558888 | MULTILAYER STRUCTURES MADE OF INDIUM PHOSPHIDE OR GALLIUM ARSENIDE | NIU, XINNING | — | §103§112 | Non-Final OA | — | Pending | Nov 03, 2023 |
| 18558943 | SEQUENCE-DEFINED POLYMERS WITH ONE OR MORE AZIDES, METHODS OF MAKING, AND METHODS OF USE THEREOF | SPANGLER, JOSEPH RANKIN | 1656 | §103§112 | Non-Final OA | — | Pending | Nov 03, 2023 |
| 18494365 | CYTOPLASMIC INCOMPATIBILITY FACTORS AND METHODS FOR CONTROLLING ANTHROPODS | MONTANARI, DAVID A | 1632 | §112Other | Non-Final OA | — | Pending | Oct 25, 2023 |
| 18557008 | ON-CHIP SPECTROMETER WITH TUNABLE PHOTODETECTION LAYER | LIU, BENJAMIN T | 2893 | §102§103 | Final Rejection | 26d overdue | Pending | Oct 24, 2023 |
| 18486265 | DEVICE, SYSTEM AND METHOD FOR CONTINUOUS ESTIMATION OF ORGAN AND TISSUE SIZE AND CONTENT WITHIN AN INTACT ORGANISM | YOON, CHANEL J | 3791 | §103§112 | Non-Final OA | — | Pending | Oct 13, 2023 |
| 18555112 | COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF CANCER | COUGHLIN, MATTHEW P | 1626 | §102§103 | Final Rejection | 13d | Pending | Oct 12, 2023 |
| 18473802 | IMIDE-BASED MODULATORS OF PROTEOLYSIS AND METHODS OF USE | MCKOY, QUINCY ANDRE | 1626 | §102 | Non-Final OA | — | Pending | Sep 25, 2023 |
| 18043436 | N-Linked Glycosylation Inhibitors and Methods of Using Same | WEDDINGTON, KEVIN E | 1629 | §102Other | Non-Final OA | 34d | Pending | Sep 22, 2023 |
| 18282206 | SYSTEMS AND METHODS FOR DETERMINING BARCODES AND SCREENING IN SITU | BUNKER, AMY M | 1684 | §102§103§112 | Non-Final OA | — | Pending | Sep 14, 2023 |
| 18465433 | TECHNIQUES FOR MITIGATING RADIATION-INDUCED ERRORS IN QUANTUM PROCESSORS | PARIHAR, SUCHIN | 2851 | §102 | Non-Final OA | — | Pending | Sep 12, 2023 |
| 18465301 | Cellular Analysis with Topology and Condensation Homology (CATCH) Analysis and Method of Use | TOKARCZYK, CHRISTOPHER B | 3687 | §102§103§112 | Non-Final OA | — | Pending | Sep 12, 2023 |
| 18547436 | TARGETED BIFUNCTIONAL DEGRADERS AND METHODS USING SAME | BRADLEY, CHRISTINA | 1654 | §103§112Other | Non-Final OA | — | Pending | Aug 22, 2023 |
| 18277505 | MULTIMODE SUPERCONDUCTING CAVITY RESONATORS | HOSSAIN, MOAZZAM | 2898 | §103 | Non-Final OA | 15d | Pending | Aug 16, 2023 |
| 18357810 | MULTIFUNCTIONAL pO2/pH-SENSITIVE THERANOSTIC LIPOSOME NANOCARRIERS AND METHODS OF USING SAME | ROSENTHAL, ANDREW S | 1613 | §103 | Final Rejection | 3d overdue | Pending | Jul 24, 2023 |
| 18270684 | HIGH-SPATIAL-RESOLUTION EPIGENOMIC PROFILING | KAPUSHOC, STEPHEN THOMAS | 1683 | §103§112DP | Non-Final OA | — | Pending | Jun 30, 2023 |
| 18266917 | USE OF MGLUR5 ANTAGONISTS FOR TREATING GAMBLING DISORDER | ROZOF, TIMOTHY R | 1625 | §103§112 | Final Rejection | 49d overdue | Pending | Jun 13, 2023 |
| 18266075 | COMPOSITIONS AND METHODS FOR TREATING, AMELIORATING, AND/OR PREVENTING VIRAL INFECTIONS | MCCORMICK, CATHERINE LYNN | 1638 | §102§103 | Non-Final OA | — | Pending | Jun 08, 2023 |
| 18323356 | MULTIPLEX DETECTION OF INTRACELLULAR OR SURFACE MOLECULAR TARGETS IN SINGLE CELLS | FLINDERS, JEREMY C | 1684 | §103 | Non-Final OA | — | Pending | May 24, 2023 |
| 18042993 | Compounds and Compositions for Disrupting Programmed Ribosomal Frameshifting | KIM, SEONG JONG | 1621 | §112 | Final Rejection | 4d overdue | Pending | Feb 24, 2023 |
| 18161712 | Bifunctional Small Molecules to Target the Selective Degradation of Circulating Proteins | LEE, JIA-HAI | 1658 | §103Other | Non-Final OA | — | Pending | Jan 30, 2023 |
| 18005444 | COMPOSITIONS AND METHODS RELATING TO TYPHOID TOXIN SUBUNIT PLTC | DEVI, SARVAMANGALA | 1645 | §103 | Final Rejection | 4d overdue | Pending | Jan 13, 2023 |
| 18000957 | COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING COAGULOPATHY AND/OR SEPSIS IN PATIENTS SUFFERING FROM BACTERIAL AND/OR VIRAL INFECTIONS | MOLOYE, TITILAYO | 1632 | §103DP | Final Rejection | — | Pending | Dec 07, 2022 |
| 18073852 | DRUG THERAPY TO INHIBIT CHEMOTHERAPY-INDUCED ADVERSE EFFECTS AND RELATED PHARMACEUTICAL COMPOSITIONS, DIAGNOSTICS, SCREENING TECHNIQUES AND KITS | NGUYEN, JOHN P | 1619 | §103 | Non-Final OA | — | Pending | Dec 02, 2022 |
| 18061272 | REGULARIZED DEEP LEARNING BASED IMPROVEMENT OF BIOMOLECULES | MOHANTA, PRAMOD KUMAR | 1686 | §101§103§112 | Non-Final OA | — | Pending | Dec 02, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialYale University has 67 pending office actions as of October 2026, spread across 44 art units and 64 examiners.
Luisalberto Gonzalez has the most, with 2 of Yale University's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
